Search by Drug Name or NDC

    NDC 68382-0536-30 Potassium Citrate 5 meq/1 Details

    Potassium Citrate 5 meq/1

    Potassium Citrate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is POTASSIUM CITRATE.

    Product Information

    NDC 68382-0536
    Product ID 68382-536_b0382b88-fcc4-44de-b66d-a93dabc596f8
    Associated GPIs 56202010200420
    GCN Sequence Number 008250
    GCN Sequence Number Description potassium citrate TABLET ER 5 MEQ ORAL
    HIC3 R1S
    HIC3 Description URINARY PH MODIFIERS
    GCN 14950
    HICL Sequence Number 000548
    HICL Sequence Number Description POTASSIUM CITRATE
    Brand/Generic Generic
    Proprietary Name Potassium Citrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Potassium Citrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units meq/1
    Substance Name POTASSIUM CITRATE
    Labeler Name Zydus Pharmaceuticals (USA) Inc.
    Pharmaceutical Class Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203546
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0536-30 (68382053630)

    NDC Package Code 68382-536-30
    Billing NDC 68382053630
    Package 10 BLISTER PACK in 1 CARTON (68382-536-30) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2014-08-12
    NDC Exclude Flag N
    Pricing Information N/A